Aligning the dosage of dopamine reuptake inhibitors with the body’s natural clocks can prolong therapeutic effects for conditions like narcolepsy, new research suggests.
Key takeaways:
- A new mathematical model indicates that taking dopamine reuptake inhibitors a few hours before the body’s natural rise in dopamine can sustain the drug’s effects for longer.
- The model, constructed using data from modafinil, suggests that improper timing can lead to sharp spikes and crashes in dopamine levels.
- While not a replacement for clinical trials, the model can be used to guide the design of studies on chronotherapeutics for narcolepsy, ADHD, and depression.
- The research also explored how these drugs interact with ultradian rhythms, which are shorter, multi-daily dopamine cycles.
Researchers at the University of Michigan have developed a mathematical model showing that circadian rhythms can significantly impact how the body interacts with certain medicines, potentially providing a basis for optimizing drug timing to improve efficacy.
The study, published in PLOS Computational Biology, focused on dopamine reuptake inhibitors (DRIs), a class of drugs used to treat narcolepsy and depression. The findings suggest that synchronizing dopamine reuptake inhibitor dosage with a patient’s natural dopamine cycle could enhance treatment outcomes.
“Our mathematical model suggests that taking DRIs a few hours before your body’s natural rise in dopamine can help prolong the treatment’s effects,” says senior author Ruby Kim, PhD, a postdoctoral research fellow with Michigan Medicine, in a release.
The model was constructed by Kim and Tianyong Yao, an undergraduate researcher in the UM Department of Mathematics, using data from modafinil, a DRI prescribed for narcolepsy. According to the researchers, the effects of modafinil can vary markedly depending on when a patient takes the drug.
“Taking modafinil at the wrong time of day can trigger sharp spikes and crashes in dopamine levels, while dosing at the right circadian window sustains dopamine levels much longer,” Yao says.
The model is not intended to replace clinical trials but to help guide them by allowing researchers to simulate different combinations of dose timing and concentration to identify promising regimens.
“Dopamine can vary a lot throughout the day, but there haven’t been many experimental studies looking at time-of-day effects,” Kim says. “Our study shows that it’s important to take these effects into account.”
The researchers believe the model could be generalized to other drugs that regulate dopamine, which are used in the management of conditions such as ADHD, fatigue, addiction, and Parkinson’s disease.
“These findings provide a mechanistic basis for chronotherapeutics—optimizing drug efficacy by considering circadian timing,” Yao says.
The model also allowed the team to investigate the interaction between modafinil and ultradian rhythms—natural cycles that affect dopamine levels multiple times a day. The model showed that DRIs lengthened each cycle of this ultradian rhythm, which could help researchers better understand its fundamental biology.
Learn More About Modafinil:
ID 416079271 © Zhumuri Mitra | Dreamstime.com
